After a long executive search, PET camera developer Positron hasfound a chief executive officer. The Houston company announcedthis month that it has hired medical imaging veteran Werner Haasas CEO. The position had been open since September of 1994,
After a long executive search, PET camera developer Positron hasfound a chief executive officer. The Houston company announcedthis month that it has hired medical imaging veteran Werner Haasas CEO. The position had been open since September of 1994, whenRobert Guezuraga stepped down (SCAN 9/28/94).
Haas is a former Siemens executive whose most recent appointmentwas chairman and CEO of x-ray digitization developer FidelityMedical (SCAN 8/26/92). At Siemens, Haas headed the Siemens MedicalInstrumentation business as well as several other Siemens unitsat various times.
Haas will inherit a company that is in the midst of a workingcapital shortage. Positron said late last year that it had enoughcapital to last through the end of 1995, but that it was unableto meet some of its financial obligations according to their standardpayment terms (SCAN 12/13/95). The company said it was under financialstrain as it purchased parts to fill several recent orders forPET cameras.
Positron is in the process of securing additional financingthat will put the company on a secure footing, according to CFODavid Rodrigue. The financing will include a bank line of creditsecured by Positron's assets and accounts receivables, as wellas a private equity placement of preferred stock and/or subordinateddebentures. The company expects the deals to be concluded in thenext 30 days.
Until then, Positron is making do with cash on hand, accordingto Rodrigue.
"With our service revenue as well as some other things,we've been able to make ends meet," he said. "Thingsare pretty close to being fixed."
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.